Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized Study Comparing Oral Valganciclovir Versus Intravenous Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation

NCT01185223 is registered in ClinicalTrials.gov with Pierrel Research Europe GmbH as lead sponsor.

NCT NCT01185223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01185223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized Study Comparing Oral Valganciclovir Versus Intravenous Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Lead sponsor
Pierrel Research Europe GmbH
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2010
Completion date
Not reported
Enrollment
212 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic stem cell transplantation